Presentations

BioCardia Corporate Presentation

The Science of CardiAMP Cell Therapy

Presentation from the 2nd Annual Acute Respiratory Distress Syndrome Drug Development Symposium

Events

July 2022

Event: Late-Stage Advancements in Heart Failure Therapeutics and Management, presented by Maxim Group LLC and hosted by M-Vest

Date: July 14, 2022, 10:00AM ET

Location: Virtual conference - live on M-Vest

Subject:  A panel discussion on heart failure with several late-stage players in the space: BioCardia, Inc. (BCDA), Mesoblast Limited (MESO), Recardio Inc. (private), and scPharmaceuticals Inc. (SCPH)

Please click here to register for the event and to access BioCardia's presentation. 

--------------------

Event: 2nd Annual Acute Respiratory Distress Syndrome Drug Development Symposium

Date: July 15, 2022, 9:10AM ET

Location: Virtual conference 

Subject: Exploring the IV NK1R+ MSC in Acute Respiratory Distress Syndrome

Please click here to register for the event and to access BioCardia's presentation. 



News

01 Dec

Empowered Patient Podcast

Optimizing Autologous Cell Therapy to Treat Cardiovascular Disease with Dr. Peter Altman
Read More
29 Oct

UW Health

UW Health Treats First Patient in U.S. with Investigational Cell Therapy for Heart Disease
Read More
29 Oct

Greenbay CBS

Neenah musician, educator pursues dream after being first in the world to undergo ‘Investigational Cell Therapy’
Read More
29 Oct

WBay.com

Neenah man gets new lease on life after trial heart procedure
Read More
04 Mar

Henry Ford Health System

Henry Ford Health System Studies Novel Cell Therapy Aimed at Improving Heart Failure Symptoms
Read More
08 Feb

Cell & Gene

Inside BioCardia's CardiAMP Cell Therapy
Read More

press releases

04 Aug
2022 BioCardia to Host Q2 2022 Financial Results and Corporate Update Conference Call on August 10, 2022
01 Aug
2022 BioCardia Announces First Canadian Clinical Site for CardiAMP Cell Therapy Heart Failure Trial
12 Jul
2022 BioCardia to Participate in Upcoming Heart and Pulmonary Therapy Development Symposia
15 Jun
2022 BioCardia Announces US Patent on Imaging System for Targeting Cardiac Therapies
11 May
2022 BioCardia Reports First Quarter 2022 Business Highlights and Financial Results
04 May
2022 BioCardia to Host Q1 2022 Financial Results and Corporate Update Conference Call on May 11, 2022
Have questions?
CALL US NOW
: (800) 624-1179
Have questions?
EMAIL US NOW
: info@biocardia.com

biocardia takes a new and comprehensive
approach to heart failure

By introducing patient screening and highly-efficient delivery to stem cell therapy, the company seeks to increase the likelihood of treatment success, enabling more patients to return to the things they love.
CLINICAL TRIALS